EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study

Jinhyun Park, Wonhui Choi, Jinseub Hwang, Ha Young Jang, Yun Kim, Young-Mi Ah, Jin-Won Kwon, Kyung Hee Choi, Yun-Kyoung Song iD

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.70027 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Jinhyun Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea. Hauptthemen laut MEDLINE: Kidney Transplantation, Sirolimus, Immunosuppressive Agents, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplant recipients (KTRs) are at high risk for cardiovascular disease due to the long‐term use of immunosuppressive therapy. This study aims to evaluate the long‐term impact of sirolimus on cardiovascular outcomes in Korean KTRs.

Methods

From a cohort of 7180 eligible KTRs identified from 2010 to 2021, 387 KTRs who received sirolimus were included. To control for confounding variables, propensity score matching was applied, and the landmark method was used to address immortal time bias. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of myocardial infarction, coronary revascularization, ischaemic stroke and all‐cause mortality.

Results

The analysis showed no significant difference in MACE between the sirolimus‐treated and untreated groups (hazard ratio, 1.40; 95% confidence interval, .77–2.55), despite a higher incidence of dyslipidaemia in the sirolimus‐treated group. However, subgroup analysis revealed an increased MACE risk in KTRs with pre‐transplant congestive heart failure (CHF) who were treated with sirolimus (hazard ratio, 6.22; 95% confidence interval, 1.78–21.74), while no significant differences were found in other subgroups.

Conclusions

These findings suggest that while sirolimus can be a viable option for immunosuppression, it should be used cautiously in those with pre‐existing CHF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationSirolimusImmunosuppressive AgentsCardiovascular DiseasesHumansFemaleMaleMiddle AgedRepublic of KoreaAdultMyocardial InfarctionMyocardial RevascularizationDyslipidemiasHeart FailureIschemic StrokePropensity ScoreAgedProportional Hazards ModelsCohort StudiesTransplant RecipientsRetrospective StudiesGraft RejectionCause of DeathMortality

Stichwörter der Autor:innen

Sirolimusadverse cardiovascular outcomeskidney transplantationmTOR inhibitors

Substanzen

SirolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea.
  • Department of Statistics, Daegu University, Gyeongsan, Korea.
  • College of Pharmacy, Gachon University, Incheon, Korea.
  • College of Pharmacy, Yeungnam University, Gyeongsan, Korea.
  • BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea.
  • College of Pharmacy, The Catholic University of Korea, Bucheon, Korea.

ORCID-Profile: Yun-Kyoung Song

Förderung

  • Ministry of Education

Zitieren

APA

Park, J., Choi, W., Hwang, J., Jang, H. Y., Kim, Y., Ah, Y. M., Kwon, J. W., Choi, K. H., & Song, Y. K. (2025). Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70027

Vancouver

Park J, Choi W, Hwang J, Jang HY, Kim Y, Ah YM, et al. Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70027

BibTeX
@article{Park2025,
  author = {Park, Jinhyun and Choi, Wonhui and Hwang, Jinseub and Jang, Ha Young and Kim, Yun and Ah, Young-Mi and Kwon, Jin-Won and Choi, Kyung Hee and Song, Yun-Kyoung},
  title = {Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.70027}
}
Kostenlos starten →